Immune Checkpoint Inhibitors in Advanced NSCLC: [<sup>18</sup>F]FDG PET/CT as a Troubleshooter in Treatment Response

Immune Checkpoint Inhibitors in Advanced NSCLC: [<sup>18</sup>F]FDG PET/CT as a Troubleshooter in Treatment Response

Introduction: The aim of this study was to investigate whether [<sup>18</sup>F]FDG PET/CT-derived semi-quantitative parameters can predict immunotherapy treatment response in non-small cell lung cancer (NSCLC) patients. Secondly, immune-related adverse events (irAEs) and lymphoid cell-ri...

Full description

Bibliographic Details
Main Authors: Cristina Ferrari, Giulia Santo, Nunzio Merenda, Alessia Branca, Paolo Mammucci, Pamela Pizzutilo, Cosmo Damiano Gadaleta, Giuseppe Rubini
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Diagnostics
Subjects:
immunotherapy
PD-1
NSCLC
[<sup>18</sup>F]FDG PET/CT
treatment response
IrAEs
Online Access:https://www.mdpi.com/2075-4418/11/9/1681

Internet

https://www.mdpi.com/2075-4418/11/9/1681

Similar Items